Cardiorespiratory adaptation to low-dose dexamethasone for lung disease in extremely preterm infants

The cardiovascular impact of dexamethasone (Dex) is not well understood. Most data are obtained from a 6 week, high-dose regimen, and are limited to findings of hypertension and cardiac hypertrophy. Arvind Sehgal discusses the impact of low-dose Dex on cardiac indices when administered to extremely preterm infants for lung disease.

Read the Study

Image courtesy of interviewee. May 30, 2023

Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.